Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
838
datasets available to search
ShareScore release 0.9.0
Dataset results
838 results for “Immunosuppressive”
Fig. 6 in Discovery of Undescribed Monoterpenoid Polyprenylated Acylphloroglucinols with Immunosuppressive Activities from Hypericum longistylum
Fig. 6. Experimental and calculated ECD spectra of 3 (A) and experimental ECD curves of compounds 3 and 4 (B) (in MeOH).
Fig. 4 in Discovery of Undescribed Monoterpenoid Polyprenylated Acylphloroglucinols with Immunosuppressive Activities from Hypericum longistylum
Fig. 4. Experimental and calculated ECD spectra of 1 (A) and experimental ECD curves of compounds 1 and 2 (B) (in MeOH).
Fig. 3. Linear correlation between experimental and calculated 13C in Discovery of Undescribed Monoterpenoid Polyprenylated Acylphloroglucinols with Immunosuppressive Activities from Hypericum longistylum
Fig. 3. Linear correlation between experimental and calculated 13C NMR chemical shifts of 1 at the B972/pcSseg-2 (A) and mPW1PW91/def2-TZVP (B) levels.
Fig. 7 in Piperazine-2,5-dione derivatives and an α-pyrone polyketide from Penicillium griseofulvum and their immunosuppression activity
Fig. 7. DP4 probabilities of 13C NMR data for both diastereoisomers of 4; comparing of experimental and calculated ECD spectra of 4-A and 4-B.
Fig. 4. Linear correlation between the experimental and calculated 13C in Piperazine-2,5-dione derivatives and an α-pyrone polyketide from Penicillium griseofulvum and their immunosuppression activity
Fig. 4. Linear correlation between the experimental and calculated 13C NMR chemical shift of 1-A and 1-B and their compared 13C NMR data (Δδ δ – δ).
Fig. 5. Linear correlation between the experimental and calculated 13C NMR chemical shifts for 1A and 1B in (±)-hyperzewalsins A D, four pairs of nor-monocyclic polyprenylated acylphloroglucinols with immunosuppressive activity from hypericum przewalskii maxim
Fig. 5. Linear correlation between the experimental and calculated 13C NMR chemical shifts for 1A and 1B.
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
ClinicalTrials.gov study NCT06532890. IPD Sharing: NO. Countries: 1. Publications: 2.
Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
ClinicalTrials.gov study NCT04382508. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Immunosuppressants in Crohn's Disease
ClinicalTrials.gov study NCT00546546. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
ClinicalTrials.gov study NCT02057796. IPD Sharing: Not stated. Countries: 4. Publications: 2.
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
ClinicalTrials.gov study NCT00275535. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
ClinicalTrials.gov study NCT00481481. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Microsampling Assays for Immunosuppressive Drugs in Children
ClinicalTrials.gov study NCT04989686. IPD Sharing: NO. Countries: 1. Publications: 23.
The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
ClinicalTrials.gov study NCT04360031. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
ClinicalTrials.gov study NCT00724022. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Immunogenicity of HPV Vaccine in Immunosuppressed Children
ClinicalTrials.gov study NCT02263703. IPD Sharing: NO. Countries: 1. Publications: 2.
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
ClinicalTrials.gov study NCT03150134. IPD Sharing: YES. Countries: 1. Publications: 10.
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
ClinicalTrials.gov study NCT04871165. IPD Sharing: NO. Countries: 1. Publications: 1.
Viral Load Guided Immunosuppression After Lung Transplantation
ClinicalTrials.gov study NCT04198506. IPD Sharing: YES. Countries: 2. Publications: 1.
Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
ClinicalTrials.gov study NCT00061360. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.